Close Menu

NEW YORK (GenomeWeb) – Nightingale Health and UK Biobank unveiled plans today to analyze metabolic biomarkers in 500,000 blood samples.

The project, which is expected to take 30 months, will focus on metabolic biomarkers previous research has linked to heart disease, type 2 diabetes, and other common chronic diseases. It will use Nightingale's NMR-based metabolite profiling platform, which the company said is able to measure more than 200 metabolites per blood sample.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.